Before prescribing or dispensing Lenalidomide Viatris, please review the Australian Approved Lenalidomide Viatris Product Information available from https://www.ebs.tga.gov.au/ and the CPMS Protocol available from the eCPMS Information page. I understand and agree to the conditions for the prescription of Lenalidomide Viatris as detailed in the CPMS Protocol, which I have read. I undertake to be bound by the obligations set out in the CPMS Protocol. As a healthcare professional participating in this activity sponsored by Viatris, I have read and understood the enclosed privacy statement and agree with it. I understand that information relating to an adverse event with a Viatris product that is identified during this activity will be forwarded to Viatris' drug safety department and possibly to health authorities when required. I understand that my participation in this activity indicates my consent for Viatris’ drug safety department to contact me for further information regarding any adverse event identified as part of this activity.